Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical grade cell manipulation.

R Giordano1, L Lazzari, P Rebulla

  • 1The Franco Calori Cell Factory, Centro Trasfusionale e di Immunologia dei Trapianti, IRCCS Ospedale Maggiore, Milan, Italy. cbbank@policlinico.mi.it

Vox Sanguinis
|September 10, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CC486 as a safe and effective bridge to transplant in MDS-del5q with transfusion-dependent anemia following lenalidomide relapse: A case report.

Current research in translational medicine·2025
Same author

Mesenchymal stem cells encapsulated into biomimetic hydrogel scaffold gradually release CCL2 chemokine in situ preserving cytoarchitecture and promoting functional recovery in spinal cord injury.

Journal of controlled release : official journal of the Controlled Release Society·2018
Same author

Usefulness of an ad hoc questionnaire (Acro-CQ) for the systematic assessment of acromegaly comorbidities at diagnosis and their management at follow-up.

Journal of endocrinological investigation·2016
Same author

Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception.

European journal of neurology·2016
Same author

Jet energy measurement and its systematic uncertainty in proton-proton collisions at [Formula: see text] TeV with the ATLAS detector.

The European physical journal. C, Particles and fields·2015
Same author

Two-particle Bose-Einstein correlations in <i>pp</i> collisions at [Formula: see text] 0.9 and 7 TeV measured with the ATLAS detector.

The European physical journal. C, Particles and fields·2015
Same journal

In vitro evaluation of apheresis platelet and plasma products collected and stored in non-DEHP disposable sets.

Vox sanguinis·2026
Same journal

Survey of national and regional rare donor programmes regarding Immunoglobulin A deficiency.

Vox sanguinis·2026
Same journal

Fibrinogen recovery in cryoprecipitate prepared from thawed plasma stored for 5 days post-thaw.

Vox sanguinis·2026
Same journal

Abstracts of the 39th International Congress of the ISBT, Kuala Lumpur, Malaysia, 20-24 June 2026.

Vox sanguinis·2026
Same journal

Development and improvement of Chinese Haemovigilance Network from 2018 to 2023.

Vox sanguinis·2026
Same journal

Marginal anaemia and perioperative transfusion in female patients undergoing cardiac surgery.

Vox sanguinis·2026
See all related articles

Cell therapy involves administering living cells for medical treatment, produced through ex vivo processes. This review covers facility design, process implementation, and quality control for these advanced therapeutic products.

Area of Science:

  • Biotechnology
  • Regenerative Medicine
  • Immunotherapy

Background:

  • Cell therapy utilizes living somatic cells for therapeutic purposes, distinct from traditional pharmaceuticals.
  • Ex vivo processes involve cell harvesting, in vitro manipulation, and patient administration.
  • Examples include hematopoietic stem cell transplantation and adoptive immunotherapy.

Purpose of the Study:

  • To review the design, construction, and validation of hospital-based facilities for cell therapy product (CTP) production.
  • To discuss the implementation of cell-manipulation processes.
  • To address quality control aspects specific to CTPs.

Main Methods:

  • Review of regulatory documents and best practices for CTP production.
  • Discussion of facility design considerations for sterile cell manipulation.

Related Experiment Videos

  • Analysis of quality control strategies for CTPs.

    • Main Results:

    • CTPs require specialized facilities and processes distinct from conventional drug manufacturing.
    • Good manufacturing practices are essential but need adaptation for CTPs.
    • Regulatory frameworks are evolving to address CTP-specific challenges.

    Conclusions:

    • Establishing dedicated facilities and robust quality control are crucial for safe and effective cell therapy.
    • Standardization of ex vivo cell processing is key to advancing cell therapy.
    • Further development in regulatory science is needed to support the growing field of cell therapy.